Infectious Disease Diagnostics Market to Reach US$ 22 Billion by - Erie News Now | WICU & WSEE in Erie, PA

Infectious Disease Diagnostics Market to Reach US$ 22 Billion by 2022

Posted:

New York, September 25, 2017 /Financeswire/: Market Research Engine has published a new report titled as “Infectious Disease Diagnostics Market By Product Analysis (Instruments & Analyzers, Assays and Reagents, Services & Software); By Application Analysis (Hepatitis B, Hepatitis C, Aids, Tuberculosis (TB), Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG), Human Papillomavirus (HPV) Infection, Methicillin-Resistant Staphylococcus Aureus (MRSA) Hospital Acquired Infection); By Technology Analysis (Traditional Diagnostic Techniques, Molecular Diagnostics); By End-User Analysis (Hospitals Laboratories, Reference Labs, Physician office Labs, Academics) and by regional analysis – global forecast by 2016 2022”

The Global Infectious Disease Diagnostics Market is segmented on the lines of its technology, product, application, End-user and regional. Based on product Analysis segmentation it covers Instruments & Analyzers, Assays and Reagents and Services & Software. Based on technology it covers Traditional Diagnostic Techniques and Molecular diagnostics. Based on End user it covers Hospitals Laboratories, Reference Labs, Physician office Labs, Academics (Academic Medical Centers/Research Labs, University Labs) and others (Blood Banks, Local Public Health Laboratories, Home Health Agencies, Nursing Homes, Point of Care, Self-Testing). Based on application segmentation it covers Hepatitis B, Hepatitis C, Aids, Tuberculosis (TB), Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG), Human Papillomavirus (HPV) Infection, Methicillin-Resistant Staphylococcus Aureus (MRSA) Hospital Acquired Infection and Others (Influenza, Ebola, Typhoid, Malaria, Dengue). Global Infectious Disease Diagnostics Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

The Global Infectious Disease Diagnostics Market is expected to exceed more than US$ 21.96 Billion by 2022 at a CAGR of 10% in the given forecast period.

Browse Full Report: https://www.marketresearchengine.com/infectious-disease-diagnostics-market

The major driving factors of Global Infectious Disease Diagnostics Market are as follows:

  • High Prevalence Rate of Infectious Diseases to Drive the Growth of Infectious Disease Diagnostics Market
  • Slow Turnaround Time of the Current Diagnostic Cycle Has Created Demand for Rapid Diagnostic Procedures

The restraining factors of Global Infectious Disease Diagnostics Market are as follows:

  • Rising Healthcare Costs Limits the Usage of Novel Infectious Disease Diagnostic Techniques
  • Complex Regulatory Framework to Delay Approvals of New Diagnostic Tests

This report provides:

1) An overview of the global market for Global Infectious Disease Diagnostics Market.
2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022.
3) Identifications of new market opportunities and targeted promotional plans for Global Infectious Disease Diagnostics Market.

4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.

Report scope:

The scope of the report includes a detailed study of Global Infectious Disease Diagnostics Market with the reasons given for variations in the growth of the industry in certain regions.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Becton Dickinson & Company, Cepheid Inc., Abbott Laboratories, BioMerieux, Hologic Inc., Bio-Rad Laboratories Inc., Danaher Corporation, Affymetrix, Alere Inc., and DiaSorin others. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

The Global Infectious Disease Diagnostics Market has been segmented as below:

By Product Analysis:

  • Instruments & Analyzers
  • Consumables
  • Assays and Reagents
  • Services & Software

By Application Analysis:

  • Hepatitis B
  • Hepatitis C
  • Aids
  • Tuberculosis (TB)
  • Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
  • Human Papillomavirus (HPV) Infection
  • Methicillin-Resistant Staphylococcus Aureus (MRSA) Hospital Acquired Infection
  • Others (Influenza, Ebola, Typhoid, Malaria, Dengue)

By Technology Analysis:

  • Traditional Diagnostic Techniques
  • Immunodiagnostics
  • Microscopy
  • Biochemical Characterization
  • Molecular Diagnostics
  • PCR
  • INAAT
  • Hybridization
  • DNA Sequencing & NGS
  • Microarray
  • Others

By End-User Analysis:

  • Hospitals Laboratories
  • Reference Labs
  • Physician office Labs
  • Academics (Academic Medical Centers/Research Labs, University Labs)
  • Others (Blood Banks, Local Public Health Laboratories, Home Health Agencies, Nursing Homes, Point of Care, Self-Testing)

By Regional Analysis:

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

 

Media Contact

Company Name: Market Research Engine

Contact Person: John Bay

Email: john@marketresearchengine.com

Phone: +1-855-984-1862

Country: United States

Website: https://www.marketresearchengine.com/

 

Source: http://www.financeswire.com/infectious-disease-diagnostics-market-to-reach-us-22-billion-by-2022

Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@franklyinc.com

Powered by Frankly
3514 State St. Erie, PA 16508
Newsroom: (814) 454-8812
Business offices: (814) 454-5201
WICU FCC Filing
WSEE FCC Filing
Share:
Share Stories
Submit your stories to our site!
Share Photos
Share your photos in our community galleries
RSS Feeds
All content © Copyright 2000 - 2017 WICU. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.
                   WICU/WSEE - 3514 State Street Erie, PA 16508 - (814) 454-5201 - info@wicu12.com